All Stories

  1. Rapid and automatic phenotyping of cells through their annexin-mediated enforced blebbing response
  2. Quercetin and MicroRNA Interplay in Apoptosis Regulation in Ovarian Cancer
  3. MicroRNA Regulation of TRAIL in Renal Carcinoma: Tiny Juggernauts at Work
  4. Ion Channels as Therapeutic Targets for Type 1 Diabetes Mellitus
  5. The applications of big data in molecular diagnostics
  6. Current and future molecular diagnostics of gastric cancer
  7. The applications of metabolomics in the molecular diagnostics of cancer
  8. Immunotherapeutic approaches in nasopharyngeal carcinoma
  9. The potential of circulating cell free RNA as a biomarker in cancer
  10. Application of NanoString technologies in companion diagnostic development
  11. The RNA Binding Protein HuR: a Promising Drug Target for Anticancer Therapy
  12. Early detection and monitoring of cancer in liquid biopsy: advances and challenges
  13. Mechanisms and Treatment Progress of Rituximab-Resistance in Diffuse Large B-cell Lymphoma
  14. Apoptosis and Anti-cancer Drug Discovery: The Power of Medicinal Fungi and Plants
  15. Tumor-secreted extracellular vesicles promote the activation of cancer-associated fibroblasts via the transfer of microRNA-125b
  16. The rise of human stem cell-derived natural killer cells for cancer immunotherapy
  17. Regulation of MicroRNAs by Phytochemicals: A Promising Strategy for Cancer Chemoprevention
  18. Implementation and new insights in molecular diagnostics for HIV infection
  19. Identification of novel drug targets for diamond-blackfan anemia based on RPS19 gene mutation using protein-protein interaction network
  20. Molecular subtyping of nasopharyngeal carcinoma (NPC) and a microRNA-based prognostic model for distant metastasis
  21. MicroRNAs as predictive biomarkers of response to tyrosine kinase inhibitor therapy in metastatic renal cell carcinoma
  22. Long noncoding RNA identification in lymphoma
  23. Patient-Derived Xenograft Models of Epithelial Ovarian Cancer for Preclinical Studies
  24. Drug combination approach to overcome resistance to EGFR tyrosine kinase inhibitors in lung cancer
  25. Mass spectrometry-based proteomics in cancer research
  26. Applications of digital PCR in precision medicine
  27. Disease Biomarkers for Precision Medicine: Challenges and Future Opportunities
  28. Editorial: Molecular Diagnostics in the Detection of Neurodegenerative Disorders
  29. Expression of Iron-Related Proteins Differentiate Non-Cancerous and Cancerous Breast Tumors
  30. Role of Autophagy and Apoptosis in Non-Small-Cell Lung Cancer
  31. Advances in Molecular Imaging of Locally Delivered Targeted Therapeutics for Central Nervous System Tumors
  32. MiR-30 Family Potentially Targeting PI3K-SIAH2 Predicted Interaction Network Represents a Novel Putative Theranostic Panel in Non-small Cell Lung Cancer
  33. The different functions and clinical significances of caveolin-1 in human adenocarcinoma and squamous cell carcinoma
  34. Precision medicine in immune checkpoint blockade therapy for non-small cell lung cancer
  35. Patient-centric research transforms medicine from an inexact science into precision medicine.
  36. Neonatal Heart-Enriched miR-708 Promotes Proliferation and Stress Resistance of Cardiomyocytes in Rodents
  37. Epigenomics
  38. Molecular Connections of Aging and Cancer
  39. Ovarian Cancer Management in the Oldest Old: Improving Outcomes and Tailoring Treatments
  40. Skin Cancer Epidemics in the Elderly as An Emerging Issue in Geriatric Oncology
  41. The Biology of Aging and Cancer: A Brief Overview of Shared and Divergent Molecular Hallmarks
  42. Cancer and Aging - the Inflammatory Connection
  43. c-MET as a Potential Therapeutic Target in Ovarian Clear Cell Carcinoma
  44. Circulating Plasma MicroRNAs As Diagnostic Markers for NSCLC
  45. Nucleotide excision repair pathway gene polymorphisms are linked to breast cancer risk in a Chinese population
  46. Immune checkpoint blockade as a potential therapeutic target in non-small cell lung cancer
  47. Expression of CD40 is a positive prognostic factor of diffuse large B-cell lymphoma treated with R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone)
  48. An oncogenic role of miR-592 in tumorigenesis of human colorectal cancer by targeting Forkhead Box O3A (FoxO3A)
  49. Prognostic performance of lymphocyte-to-monocyte ratio in diffuse large B-cell lymphoma: an updated meta-analysis of eleven reports
  50. Drug Transporters and Multiple Drug Resistance in the Most Common Pediatric Solid Tumors
  51. Genome-Wide Identification of a Methylation Gene Panel as a Prognostic Biomarker in Nasopharyngeal Carcinoma
  52. Inhibition of CD147 expression by RNA interference reduces proliferation, invasion and increases chemosensitivity in cancer stem cell-like HT-29 cells
  53. Novel structural co-expression analysis linking the NPM1-associated ribosomal biogenesis network to chronic myelogenous leukemia
  54. MicroRNAs as regulators of airborne pollution-induced lung inflammation and carcinogenesis
  55. The role of microRNAs in toxicology
  56. Application of oncoproteomics to aberrant signalling networks in changing the treatment paradigm in acute lymphoblastic leukaemia
  57. Towards developing biomarkers for glioblastoma multiforme: a proteomics view
  58. Application of microRNAs in diabetes mellitus
  59. Colorectal cancer biomarker discovery and validation using LC-MS/MS-based proteomics in blood: truth or dare?
  60. Methenamine: a forgotten drug for preventing recurrent urinary tract infection in a multidrug resistance era
  61. Proteomics in translational cancer research: biomarker discovery for clinical applications
  62. Lectin approaches for glycoproteomics in FDA-approved cancer biomarkers
  63. Biomarker discovery of nasopharyngeal carcinoma by proteomics
  64. Potential of antibody–drug conjugates and novel therapeutics in breast cancer management
  65. Stratification of clear cell renal cell carcinoma by signaling pathway analysis
  66. Putative biomarkers and therapeutic targets associated with radiation resistance
  67. Emerging techniques in molecular detection of circulating tumor cells
  68. Chinese Versus Western Medicine
  69. Epigenomics
  70. The role of acupoint stimulation as an adjunct therapy for lung cancer: a systematic review and meta-analysis
  71. Mapping the interactome of overexpressed RAF kinase inhibitor protein in a gastric cancer cell line
  72. Trastuzumab emtansine for advanced HER2-positive breast cancer and beyond: genome landscape-based targets
  73. Cell Budding from Normal Appearing Epithelia: A Predictor of Colorectal Cancer Metastasis?
  74. Targeting signaling pathways in lung cancer therapy
  75. Theranostics: rethinking postgenomic diagnostics
  76. MicroRNAs as therapeutic targets and their potential applications in cancer therapy
  77. Great potential of miRNAs as predictive and prognostic markers for cancer
  78. Genomic Sequence Analysis of EGFR Regulation by MicroRNAs in Lung Cancer
  79. Exploiting the therapeutic potential of microRNAs in human cancer
  80. Targeting the signaling pathways in cancer therapy
  81. Tube-Like Structures with Co-Expression of D2-40 and CD34: Newly Formed Vasculatures?
  82. Proteome profiling for the identification of lung cancer signatures
  83. Promises and challenges in developing miRNA as a molecular diagnostic tool for lung cancer
  84. Epigenetic alteration of microRNAs in feces of colorectal cancer and its clinical significance
  85. The role of inflammation in the pathogenesis of lung cancer
  86. Proteomics and translational medicine: molecular biomarkers for cancer diagnosis, prognosis and prediction of therapy outcome
  87. MiR-145 inhibits cell proliferation of human lung adenocarcinoma by targeting EGFR and NUDT1
  88. Molecular diagnostics for monitoring and predicting therapeutic effect in cancer
  89. MicroRNAs in Cancer Translational Research
  90. Conquering cancer through discovery research
  91. MicroRNAs as therapeutic targets for lung cancer
  92. Recent progress in genetic variants associated with cancer and their implications in diagnostics development
  93. Supportive Cancer Care with Chinese Medicine
  94. An Omics Perspective on Cancer Research
  95. Role of miRNAs in lung cancer
  96. Cancer research on non-small cell lung cancer in smokers and non-smokers: snapshots from the AACR annual meeting 2009
  97. Updates in cancer research: insights from the AACR 100th Annual Meeting
  98. Transcatheter arterial chemoembolization combined with or without Chinese herbal therapy for hepatocellular carcinoma: meta-analysis
  99. Oncoproteomics: current trends and future perspectives
  100. OncomiRs: the discovery and progress of microRNAs in cancers
  101. Contribution of oncoproteomics to cancer biomarker discovery
  102. Altered Expression of miR-21, miR-31, miR-143 and miR-145 Is Related to Clinicopathologic Features of Colorectal Cancer
  103. Immunopharmacological Studies of Low Molecular Weight Polysaccharide from Angelica Sinensis
  104. Proteinchip